- ISSN 1672-5069
- CN 34-1270/R
- CODEN SGZHBF
JOURNAL OF PRACTICAL HEPATOLOGY ›› 2011, Vol. 14 ›› Issue (4): 321-324.doi: 10.3969/j.issn.1672-5069.2011.04.037
Received:2011-03-21
Online:2011-08-10
Published:2016-04-15
| [1] CSAK T，GANZ M，KODYS K，et al. Inflammasome activation occurs in NASH in vivo and it is mediated by fatty acids through sensitization to LPS-induced inflammasome activation in hepatocytes[J]. Hepatology，2010，52（S1）:77A. [2] ZHANG Y，LIU SH，LEE CH，et al. Mice lacking thioesterase superfamily member1（THEM1）/STARD14 are protected against diet-induced hepatic steatosis: role of white adipose inflammation[J]. Hepatology，2010，52（S1）:1043A-1044A. [3] KAMADA Y，KISO S，YOSHIDA Y，et al. Estrogen deficiency enhanced the progression of steatohepatitis with increased macrophage infiltration in mice fed with high fat and high cholesterol diet[J]. Hepatology，2010，52（S1）:1051A. [4] BANZ V，CLARIDGE LC，KAVANAGH DP，et al. Kupffer cell dependent IL-17 secretion and Th17 cell recruitment drives murine steatohepatitis[J]. Hepatology，2010，52（S1）:1045A-1046A. [5] THAPALIYA S，BERK MP，DIXON LJ，et al. Role of BAX activation in steatohepatitis development in vivo[J]. Hepatology， 2010，52（S1）:1048A. [6] DIXON LJ，BERK MP，THAPALIYA S，et al. Caspase 1-mediated regulation of fibrogenesis in diet-induced steatohepatitis[J]. Hepatology，2010，52（S1）:77A. [7] RANGWALA F，GUY CD，JIUYI LU，et al. increased production of sonic hedgehog by ballooned hepatocytes: implications for fibrosis progression in NASH[J]. Hepatology，2010，52（S1）:78A. [8] KUMAMOTO R，UTO H，TANOUE S，et al. Dietary fructose rather than dietary fat affects liver tumor incidence induced by diethylnitrosamine administration in rats[J]. Hepatology，2010，52（S1）:1042A. [9] SYDOR S，GU Y，SOWA JP，et al. Western diet enhances expression of death receptors and fatty acid transporters in a mouse model of 70% hepatectomy and leads to increased cell proliferation in the liver[J]. Hepatology，2010，52（S1）:1056A. [10] IKEJIMA K，YAMAGATA H，ARAI K，et al. Depletion of natural killer T cells increases the susceptibility to dietary-induced steatohepatitis in mice[J]. Hepatology，2010，52（S1）:1041A. [11] SAWADA K，OHTAKE T，HASEBE T，et al. Disturbance of hepatic and intestinal Toll-like receptor signal pathway in high-fat diet induced NAFLD model mice[J]. Hepatology， 2010，52（S1）:1061A-1062A. [12] JI C，LAU MY，PETROVIC LM，et al. liver specific deletion of the key chaperone GRP78/BIP aggravates a spectrum of acute and chronic stress-induced liver injury[J]. Hepatology，2010，52（S1）:78A. [13] SOON RK，YAN JS，GRENERT JP，et al. Stress signaling in the methionine-choline-deficient model of murine fatty liver disease[J]. Hepatology，2010，52（S1）:1043A. [14] KON K，IKEJIMA K，SAITO H，et al. Trans-fatty acid induces apoptosis of hepatocytes by enhancement of oxidative stress in steatotic liver of KK-AY mice[J]. Hepatology，2010，52（S1）: 1053A-1054A. [15] BAFFY G，NEUSCHWANDER-TETRI BA. Genetics and environment in the progression of NAFLD[J]. Hepatology， 2010，52（S1）:110A [16] DASARATHY S，YANG Y，RUNKANA A，et al. Differential effects of diet and genetic background on hepatic microRNA expression in diet induced NAFLD[J]. Hepatology，2010，52（S1）: 1058A-1059A. [17] PASRICHA S，KENNEY-HUNT J，CHEVERUD J，et al. Quantitative trait loci（QTL）analysis of fatty liver disease[J]. Hepatology，2010，52（S1）:1054A. [18] FRANCQUE S，VERLINDEN W，BROSIUS I，et al. Vascular hyporeactivity in steatosis-induced portal hypertension is mediated by a special cyclooxygenase 2-related mechanism[J]. Hepatology，2010，52（S1）:1040A-1041A. [19] COULON SH，GEERTS AM，CASTELEYN C，et al. Presence of liver angiogenesis and upregulation of VEGF in a mice model of non-alcoholic steatohepatitis（NASH）[J]. Hepatology，2010，52（S1）:1062A-1063A. [20] BUCK M，CHOJKIER M. TNF-α induced phosphorylation of C/EBPβ serine-239 is critical for the development of obesity and fatty liver[J]. Hepatology，2010，52（S1）:77A. [21] MOYLAN CA，ABDELMALEK MF，PANG H，et al. Signals from the fibrostic liver in patients with NAFLD may promote diabetes and obesity[J]. Hepatology，2010，52（S1）:1049A-1050A. [22] LANTHIER N，MOLENDI-COSTE O，CANI PD，et al. Cross-talk between kupffer cells and adipose tissue in the pathogenesis of IR[J]. Hepatology，2010，52（S1）:1045A. [23] STOLL JM，SHRESTHA S，SCAPA EF，et al. Resistance to diet induced diabetes due to reduced hepatic glucose production in mice lacking phosphatidylcholine transfer protein（PC-TP）[J]. Hepatology，2010，52（S1）:1053A. [24] SONG M，SCHUSCHKE D，ZHOU Z，et al. High fructose feeding induces copper deficiency: a novel mechanism for obesity related fatty liver[J]. Hepatology，2010，52（S1）:1058A. [25] SIDDIQUI MS，SIDDIQUI MB，GREEN RM. Metabolic syndrome resistant A/J mice fed a high fat diet down regulate SREBP-1c activity and function[J]. Hepatology，2010，52（S1）:1063A. [26] SYN WK，CHOI SS，LIASKOU E，et al. osteopontin promotes NAFLD progression[J]. Hepatology，2010，52（S1）:77A. [27] SKOIEN R，POWELL EE， MELINO M，et al. Fatty acids induce hepatocyte senescene in vitro: implications for pathogenesis in NASH[J]. Hepatology，2010，52（S1）:1044A-1045A. [28] KANURI G，SPRUSS A，WAGNERBERGER S，et al. Critical role of plasminogen activator inhibitor（PAI-1），microsomal triglyceride transfer protein（MTTP）and NKT cells in the onset of fructose-induced steatosis in mice[J]. Hepatology，2010，52（S1）:1049A. [29] ARIAZU E，LEUNG TM，PAGANOS S，et al. SPP1 contributer to NASH in mice fed a methionine-choline deficient diet[J]. Hepatology，2010，52（S1）:1053A. [30] KANG HW，COHEN DE. Interactions between thioesterase superfamily member 2（THEM2）and phosphatidylcholine transfer protein（PC-TP）limit hepatic triglyceride secretion[J]. Hepatology，2010，52（S1）:1056A. [31] SYDOR S，SOWA JP，TRECKMANN J，et al. Increased expression of FABP-1 and CFLIPL by free fatty acid treatment is associated with reduced death-receptor mediated apoptosis and ERK-activation in human primary hepatocytes[J]. Hepatology， 2010，52（S1）:1056A-1057A. [32] ZUfiIGA S，FIRRINCIELI D，LASNIER E，et al. Invalidation of the vitamin D nuclear receptor promotes liver steatosis[J]. Hepatology，2010，52（S1）:1021A-1119A. [33] LOKMAN KA，PLEVRIS-PAPAIOANNOU A，BAREN JP，et al. The effect of free fatty acid and reactive oxygen species on CIDEB expression in in vitro model of steatosis[J]. Hepatology，2010，52（S1）:1059A-1060A. [34] SOFTIC S，KIRBY M，SHROYER N，et al. Insulin signaling mediates hepatic steatosis through fatty acid transport proteins （FATPS）in a U-shaped dose dependent manner[J]. Hepatology，2010，52（S1）:1060A. [35] IMAJO K，FUJITA K，NOZAKI Y，et al. Decrease in hepatic microsomal triglyceride transfer protein mRNA levels and pathological progression induced by lipopolysaccharide in a murine NASH model[J]. Hepatology，2010，52（S1）:1060A-1061A. [36] VIKER K，KRISHNAN A，SANDERSON SO，et al. The fast food diet mouse-a novel small animal model of NASH with progressive fibrosis and high fidelity to the human condition[J]. Hepatology，2010，52（S1）:1046A-1047A. [37] WU J，SCHIE IW，VEMURI M，et al. A new mouse model of NASH created by feeding diet containing conjugated linoleic acid[J]. Hepatology，2010，52（S1）:1057A. [38] FOLLI F，CHAVEZ A，CASIRAGHI F，et al. The baboon as a model of NAFLD. Increased intra-hepatic fat content and impairment in the insulin signaling cascade in obese/IR non-human primates[J]. Hepatology，2010，52（S1）:1059A. [39] GUPTA NA，KWUN J，KIRK AD，et al. Role of GLP-1R agonists in decreasing hepatic steatosis and apoptosis in ob/ob mice undergoing ischemia reperfusion injury[J]. Hepatology， 2010，52（S1）:1041A-1042A. [40] RECTOR RS， UPTERGROVE G，MORRIS M，et al. Attenuation of weight gain through daily exercise versus caloric restriction and prevention of NAFLD in hyperphagic OLETF rats[J]. Hepatology，2010，52（S1）:1042A. [41] SOLFIS-MUFOOZ P，GARCA-RUIZ I，GMEZ-IZQUIERDO E，et al. Effects of melatonin on the mitochondrial respiratory chain（MRC）complexes and liver histology in ob/ob mice with NAFLD[J]. Hepatology，2010，52（S1）:1043A. [42] UENO T，NAKAMURA A，NAKAMURA T，et al. Adiponectin suppresses endoplasmic reticulum（ER）stress in nonalcoholic steatohepatitis（NASH）[J]. Hepatology，2010，52（S1）:1044A. [43] LIANG M，PECORA BS，WANG X，et al. Raltegravir prevents hepatic steatosis due to HIV protease inhibitors by enhancing autophagy[J]. Hepatology，2010，52（S1）:1046A. [44] OKADA Y，NISHIKAWA T，JO M，et al. Rosuvastatin improves hepatic inflammation and fibrosis through the inhibition of oxidative stress in rats NASH model[J]. Hepatology，2010，52（S1）: 1047A. [45] ADAR T，LICHTENSTEIN Y，LALAZAR G，et al. Induction of CD4+CD25+FOXP3+ regulatory T cells by oral administration of IgG-enhanced colostrum suppressed the chronic inflammatory state in ob/ob mice alleviating the insulin resistance and liver injury[J]. Hepatology，2010，52（S1）:1047A. [46] MELLS JE，FU PP，HANDY JA，et al. Daily administration of liraglutide ameliorates the deleterious effects of high-fructose corn syrup and trans-fat feeding in C57BL6 mice-implications for NAFLD[J]. Hepatology，2010，52（S1）: 1048A. [47] SALAMONE F，VOLTI GL. Silybin improves liver injury and adipose tissue inflammation in mice with NAFLD[J]. Hepatology，2010，52（S1）:1049A. [48] TREVASKIS JL，GRIFFIN P，WITTMER C，et al. Glucagon-like peptide-1（GLP-1）receptor agonism improves biochemical and histopathological indices of NASH in mice[J]. Hepatology，2010，52（S1）:1061A. [49] LAVALLARD V，BONNAFOUS S，ROUSSEAU D，et al. Role of autophagy in hepatocyte death in NASH[J]. Hepatology，2010，52（S1）:1050A-1051A. [50] MAZO DF，PEREIRA IV，LIMA VM，et al. S-nitroso-N-acetylcysteine （SNAC），a nitric oxide donor，modulated hepatic stellate cells（HSCS）activity and has antifibrogenic properties in experimental nonalcoholic steatohepatitis（NASH）[J]. Hepatology，2010，52（S1）:1052A. [51] DERDAK Z，VILLEGAS KA，WANDS JR. The P53 inhibitor， pifithrin-alpha P-nitro attenuates NAFLD in mice[J]. Hepatology，2010，52（S1）:1052A. [52] ADAR T，LALAZAR G，ZOLOTAROV L，et al. Increased AKT phosphorylation alleviates insulin resistance and its associated liver injury: a synergistic effect of oral insulin and beta glycolipid[J]. Hepatology，2010，52（S1）:1054A-1055A. [53] KAJIKAWA S，IMADA K，TAKEUCHI T，et al. The therapeutic effect of eicosapentaenoic acid against hepatic fibrosis in a rat model of NASH[J]. Hepatology，2010，52（S1）:1055A. [54] LEE JI， LEE JW，KIM YS，et al. Effect of sylimarin on methinnie-choline deficient diet induced NASH in IR rats[J]. Hepatology，2010，52（S1）:1055A. [55] MALHI H，KROPP E，KAUFMAN RJ. C/EBP homologous protein（CHOP）protects mice from NASH[J]. Hepatology，2010，52（S1）:1057A. [56] ADAR T，ZOLOTAROV L，LALAZAR G，et al. Steroid induced insulin resistance and its associated liver injury can be reversed by beta-glucosylceramide. A novel hepatoprotective co-adjuvant treatment strategy for steatohepatitis[J]. Hepatology， 2010，52（S1）:1057A-1058A. [57] TREVASKIS JL，GRIFFIN P，TATARKIEWICZ K，et al. Exenatide exhibits significant antisteatotic actions in diabetic LEPOB/LEPOB mice compared to sitagliptin and pioglitazo-ne[J]. Hepatology，2010，52（S1）:1050A. [58] JUN DW，CHO WK，KWON HJ，et al. Prevention of free fatty acid induced hepatic lipotoxicity by carnitine through restoration of mitochondrial dysfunction[J]. Hepatology，2010，52（S1）: 1062A. [59] SETSHEDI M，TONG M，FENG D，et al. Ceramide inhibitors and PPAR agonists ameliorate alcohol-induced steatohepatitis in an ex-vivo liver slice culture model[J]. Hepatology，2010，52（S1）:1063A. [60] HAN Y，JING Q，FRANCIS H，et al. Emerging roles of microRNAs in the control of apoptosis and transformation in hepatobiliary cells during alcoholic liver disease[J]. Hepatology， 2010，52（S1）:379A. [61] LIN CW，TSAI MH，CHEN X，et al. Enhanced autophagy alleviated ethanol-induced fatty liver in mouse[J]. Hepatology， 2010，52（S1）:379A-380A. [62] AMBADE A，CATALANO D，MANDREKAR P. Targeting HSP90，a molecular chaperone in alcoholic liver injury: inhibition of LPS-induced TNFα production[J]. Hepatology，2010，52（S1）:380A. [63] LEVIN I，NATH B，KURT-JONES EA，et al. Activation of hypoxia inducible factor 1-alpha in hepatocytes requires toll like receptor 4 dependent pathways and results in steatosis in a mouse model of chronic ethanol challenge[J]. Hepatology，2010，52（S1）:380A-381A. [64] DERDAK Z，VILLEGAS KA，WANDS JR. Fibrosis-related transcription factor early growth response-1（EGR-1）promotes steatosis in the liver of ethanol-fed long-evans rats by activating sterol regulatory element binding protein-1（SREBP1）[J]. Hepatology，2010，52（S1）:1112A. [65] KIRPICH I，ZHANG JW，GOBEJISHVILI L，et al. Binge alcohol-induced microvesicular liver steatosis and injury are associated with down-regulation of hepatic HDACS 1，7，9，10，11 and up-regulation of HDAC 3[J]. Hepatology，2010，52（S1）:1113A. [66] HOWARTH DL，SADLER KC. ATF-6 and the unfolded protein response play a key role in acute ethanol-induced steatosis in zebrafish[J]. Hepatology，2010，52（S1）:1113A. [67] DEGRFI D，LEMMERS A，GUSTOT T，et al. Correlation between CCL2（MCP-1），neutrophils recruitment and disease severity in alcoholic hepatitis: a potential IL-17 dependent pathway[J]. Hepatology，2010，52（S1）:1113A-1114A. [68] KI SH，PARK O，ZHENG MQ，et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic plus binge ethanol feeding: role of STAT3[J]. Hepatology，2010，52（S1）:1115A. [69] TR?PO E，GUSTOT T，DEGRE D，et al. Common polymorphism in PNPLA3 gene in associated with stetosis and cirrhosis in alcoholic liver disease[J]. Hepatology，2010，52（S1）:381A. [70] LOUVET A，ARTRU F，WARTEL F，et al. Long-term data in severe alcoholic hepatitis: alcohol relapse is the key factor of survival[J]. Hepatology，2010，52（S1）:381A. [71] ALTAMIRANO J，BATALLER R，FAGUNDES C，et al. Acute kidney injury（AKI）negatively impacts short-term survival in patients with alcoholic hepatitis: implications for therapy[J]. Hepatology，2010，52（S1）:1108A. [72] LOUVET A，ARTRU F，DIAZ E，et al. Prognostic scores are efficient in patients with severe alcoholic hepatitis treated with corticosteroids: comparison of available models[J]. Hepatology， 2010，52（S1）:1108A-1109A. [73] LOUVET A，ARTRU F，WARTEL F，et al. A response-guided therapy for a better management of patients severe alcoholic hepatitis treated with corticosteroids[J]. Hepatology，2010，52（S1）:1109A. [74] HIRAMINE Y，IMAMURA Y，UTO H，et al. Alcohol drinking patients and the risk of fatty liver in Japanese men[J]. Hepatology，2010，52（S1）:1109A-1110A. [75] AMATHIEU R，NAHON P，TRIBA MN，et al. Metabolomic approach by proton NMR spectroscopy of blood serum for the assessment of chronic liver failure in alcoholic cirrhosis patients[J]. Hepatology，2010，52（S1）:1110A. [76] ELLEFSON WM，LAKNER AM，MCKILLOP LH，et al. Hormonal imprinting influences early alcohol-induced liver injury[J]. Hepatology，2010，52（S1）:1110A-1111A. [77] LOUVET A，DELTENRE P，ARTRU F，et al. Hepatic venous pressure gradient in severe alcoholic hepatitis is not associated with survival:a prospective study[J]. Hepatology，2010，52（S1）:1119A. [78] ASRANI SK，LARSON JJ，BENSON JT，et al. Survival of patients with alcoholic hepatitis: a population-based study[J]. Hepatology，2010，52（S1）:1111A. [79] SINGAL AK，ANDERSON KE，KUO YF. Hepatitis C virus infection and increased severity of acute alcoholic hepatitis in a large national inpatient data sample[J]. Hepatology，2010，52（S1）:1112A. [80] THULUVATH PJ，NGUYEN GC. Impact of HCV and hepatic encephalopathy on the outcome of patients admitted with alcoholic hepatitis[J]. Hepatology，2010，52（S1）:1114A. [81] LIANGPUNSAKUL S. Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States[J]. Hepatology，2010，52（S1）:1114A. |
| No related articles found! |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
